Bookmark and Share
Ethionamide (CID 2761171) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(17)
 
 
Inactive(1769)
 
 
Inconclusive(87)
 
 
Unspecified(1286)
 
 
Top Targets:
7tm 4(71)
 
 
NR LBD PPAR(40)
 
 
 
NR LBD AR(25)
 
 
 
NR LBD ER(25)
 
 
 
 
NR LBD TR(23)
 
 
 
BioAssay Types:
Confirmatory(828)
 
 
 
 
 
Screening(754)
 
 
 
 
Literature(214)
 
 
 
 
 
Summary(72)
 
 
 
BioActivity Types:
Potency(750)
 
 
 
 
 
IC50(69)
 
 
 
 
EC50(8)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 2250    Data Row: 3159   Total Pages: 158   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID144209607]
Potency-Replicate_1 5.3984qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line [AID743079, Type: confirmatory]estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627]
View
2
[SID103512882]
IC50 6.75Antimycobacterial activity against Mycobacterium smegmatis by GFP-based fluorescence assay [AID562239, Type: Literature]
View
3
[SID103512882]
IC50 7.66Antimycobacterial activity against Mycobacterium smegmatis assessed as growth inhibition in mid-logarithmic phase by spectrophotometry [AID562238, Type: Literature]
View
4
[SID85148756]
IC50 (with Meropenem) 8.455Screen and Counter Screen to Identify Novel Compounds that Selectively Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics [AID434987, Type: confirmatory]
View
5
[SID85148756]
IC90 12.788Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics [AID434955, Type: confirmatory]
View
6
[SID103512882]
Inhibition of mycolic acid synthesis in Mycobacterium bovis BCG NCTC 5692 with ethR-knockout mutant assessed as incorporation of [2-14C]acetate [AID283665, Type: Literature]
View
7
[SID48413732]
DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results [AID1189, Type: other]
View
8
[SID48413732]
DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results [AID1199, Type: other]
View
9
[SID48415974]
DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other]
View
10
[SID49698701]
High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv [AID1332, Type: confirmatory]
View
11
[SID103512882]
IC50 Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 6 days by MTT assay [AID649473, Type: Literature]
View
12
[SID103512882]
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv [AID713897, Type: Literature]
View
13
[SID11112402]
p450-cyp1a2 [AID410, Type: confirmatory]cytochrome P450 1A2 [Homo sapiens] [gi:73915100]
View
14
[SID11532957]
uHTS of Mcl-1/Noxa interaction inhibitors [AID1022, Type: screening]Mcl-1 [Homo sapiens] [gi:7582271]
View
15
[SID103512882]
Enoyl-[acyl-carrier-protein] reductase inhibitor [AID742802, Type: Literature]Enoyl-[acyl-carrier-protein] reductase [NADH] [gi:614084752]
View
16
[SID103512882]
Enoyl-[acyl-carrier-protein] reductase inhibitor [AID742802, Type: Literature]Enoyl-[acyl-carrier-protein] reductase [NADH] [gi:614084752]
View
17
[SID103512882]
Enoyl-[acyl-carrier-protein] reductase inhibitor [AID742802, Type: Literature]Enoyl-[acyl-carrier-protein] reductase [NADH] [gi:614084752]
View
18
[SID85148756]
Potency qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory]acid sphingomyelinase [Homo sapiens] [gi:179095]
View
19
[SID56422118]
Potency qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory]acid sphingomyelinase [Homo sapiens] [gi:179095]
View
20
[SID103512882]
Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Pathology; Tissue: Liver; Assay: Single Cell Necrosis; Study_ID: 584/5 [AID781634, Type: other]
View